Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Cameco Corp
expected to post earnings of 20 cents a share - Earnings Preview
Cameco Corp CCJ.N, CCJ is expected to show a rise in quarterly revenue when it reports results on May 1 for the period ending March 31 2025The Saskatoon Saskatchewan-based company is expected to report a 29.0% increase in revenue to C$817.96 million from C$634 million a year ago, according to the ...
Reuters
Tue, Apr 29
Idacorp Inc
expected to post earnings of $1.05 a share - Earnings Preview
Idacorp Inc IDA.N, IDA is expected to show a fall in quarterly revenue when it reports results on May 1 for the period ending March 31 2025The Boise Idaho-based company is expected to report a 5.7% decrease in revenue to $423.305 million from $448.94 million a year ago, according to the mean estim...
Reuters
Tue, Apr 29
Golden Matrix Group Repays And Retires Lind Global Convertible Note, Eliminating $7.2 Million In Debt
Golden Matrix Group Inc GMGI.O:GOLDEN MATRIX GROUP REPAYS AND RETIRES LIND GLOBAL CONVERTIBLE NOTE, ELIMINATING $7.2 MILLION IN DEBTSource text: [ID:n0001477932-25-003049]
Reuters
Tue, Apr 29
Pearl Diver Credit Company Inc. Announces First Quarter 2025 Financial Results
Pearl Diver Credit Company Inc PDCC.N:PEARL DIVER CREDIT COMPANY INC. ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS
Reuters
Tue, Apr 29
Myers Industries Inc
expected to post earnings of 19 cents a share - Earnings Preview
Myers Industries Inc MYE.N, MYE is expected to show a fall in quarterly revenue when it reports results on May 1 for the period ending March 31 2025The Akron Ohio-based company is expected to report a 0.1% decrease in revenue to $206.8 million from $207.1 million a year ago, according to the estim...
Reuters
Tue, Apr 29
Genuine Parts Company Announces Changes To The Board And Declares Regular Quarterly Dividend
Genuine Parts Co GPC.N:GENUINE PARTS COMPANY ANNOUNCES CHANGES TO THE BOARD AND DECLARES REGULAR QUARTERLY DIVIDEND
Reuters
Tue, Apr 29
Velo3d Announces $22 Million Long-Term, Exclusive Supply Agreement With Amaero
Amaero Ltd 3DA.AX:VELO3D ANNOUNCES $22 MILLION LONG-TERM, EXCLUSIVE SUPPLY AGREEMENT WITH AMAERO
Reuters
Tue, Apr 29
Heartbeam Successfully Meets Clinical Endpoints In Pivotal Study For Its Groundbreaking 12-Lead ECG Synthesis Technology
Heartbeam Inc BEAT.O:HEARTBEAM SUCCESSFULLY MEETS CLINICAL ENDPOINTS IN PIVOTAL STUDY FOR ITS GROUNDBREAKING 12-LEAD ECG SYNTHESIS TECHNOLOGY
Reuters
Tue, Apr 29
Franklin Financial Services Corp QTRLY EPS $0.88
Franklin Financial Services Corp FRAF.O:FRANKLIN FINANCIAL SERVICES CORP: QTRLY EPS $0.88Source text: [ID:n0000723646-25-000031]
Reuters
Tue, Apr 29
Laser Photonics Subsidiary CMS Laser Wins Major Order From Fortune 500 Appliance Leader
April 29 (Reuters) - Laser Photonics Corp LASE.O:LASER PHOTONICS SUBSIDIARY CMS LASER WINS MAJOR ORDER FROM FORTUNE 500 APPLIANCE LEADER
Reuters
Tue, Apr 29
BREAKINGVIEWS-Mark Carney’s winning issue is now another problem
By Pranav Kiran TORONTO, April 29 (Reuters Breakingviews) - Donald Trump is on a self-declared mission of American revitalization. He’s resurrecting the fortunes of his political foils first. In polls held Monday, the Liberal Party and its leader, Prime Minister Mark Carney, won a renewed mandat...
Reuters
Tue, Apr 29
Ferrari unveils new 296 Speciale hybrid models ahead of EV launch
Presents 296 Speciale hybrid, plus convertible version296 Speciale priced around $450,000 in Italy; US will be higherComes ahead of Ferrari's first fully electric car in October MARANELLO, Italy, April 29 (Reuters) - Ferrari RACE.MI refreshed its hybrid range on Tuesday with the new 296 Speci...
Reuters
Tue, Apr 29
Pfizer - Expects About $1.6 Bln One-Time Costs To Achieve Additional Savings To Be Incurred Through 2027 - SEC Filing
April 29 (Reuters) - Pfizer Inc PFE.N:PFIZER - EXPECTS ABOUT $1.6 BILLION ONE-TIME COSTS TO ACHIEVE ADDITIONAL SAVINGS TO BE INCURRED THROUGH 2027 - SEC FILINGPFIZER INC - EXPECTS $500 MILLION SAVINGS FROM RESEARCH AND DEVELOPMENT SIMPLIFICATION BY 2026 - SEC FILINGPFIZER INC - EXPECTS $600 MILLION ...
Reuters
Tue, Apr 29
Cbre Group Announces Pricing Of $600 Mln Senior Notes Due 2030
April 29 (Reuters) - CBRE Group Inc CBRE.N:CBRE GROUP, INC. ANNOUNCES PRICING OF $600 MILLION SENIOR NOTES DUE 2030 AND $500 MILLION SENIOR NOTES DUE 2035
Reuters
Tue, Apr 29
Alcresta Therapeutics Announces Enrollment Of First Patient In Clinical Trial Evaluating Use Of Relizorb
April 29 (Reuters) - ALCRESTA THERAPEUTICS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN CLINICAL TRIAL EVALUATING USE OF RELIZORB IN PANCREATITIS PATIENTS AT MASSACHUSETTS GENERAL HOSPITALFurther company coverage: [ ]
Reuters
Tue, Apr 29
Moody's Ratings Changes Thailand's Outlook To Negative From Stable; Affirms Baa1 Ratings
April 29 (Reuters) - Moody's:MOODY'S RATINGS CHANGES THAILAND'S OUTLOOK TO NEGATIVE FROM STABLE; AFFIRMS BAA1 RATINGSMOODY'S: DECISION TO CHANGE OUTLOOK TO NEGATIVE FROM STABLE CAPTURES RISKS THAT THAILAND'S ECONOMIC & FISCAL STRENGTH WILL WEAKEN FURTHERMOODY'S: US TARIFF...
Reuters
Tue, Apr 29
Neogenomics And Ultima Genomics Collaborate To Expand Clinical Test Offerings In Oncology
April 29 (Reuters) - Neogenomics Inc NEO.O:NEOGENOMICS AND ULTIMA GENOMICS COLLABORATE TO EXPAND CLINICAL TEST OFFERINGS IN ONCOLOGY USING THE UG 100 SEQUENCING PLATFORM
Reuters
Tue, Apr 29
Palatin Announces Breakthrough Symptom Resolution in Updated Analyses from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease
April 29 (Reuters) - Palatin Technologies Inc PTN.A:PALATIN ANNOUNCES BREAKTHROUGH SYMPTOM RESOLUTION IN UPDATED ANALYSES FROM PHASE 3 PL9643 MELODY-1 CLINICAL TRIAL IN DRY EYE DISEASE
Reuters
Tue, Apr 29
Travelzoo Reports First Quarter 2025 Results
Travelzoo TZOO.O:TRAVELZOO REPORTS FIRST QUARTER 2025 RESULTSTRAVELZOO: FOR Q2 2025, WE EXPECT YEAR-OVER-YEAR REVENUE GROWTH TO DOUBLE
Reuters
Tue, Apr 29
RINVOQ (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA)
April 29 (Reuters) - Abbvie Inc ABBV.N:RINVOQ® (UPADACITINIB) RECEIVES U.S. FDA APPROVAL FOR GIANT CELL ARTERITIS (GCA)
Reuters
Tue, Apr 29
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free